Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status (Q66077055)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Olaparib Tablets as a Treatment for Ovarian Cancer Subjects With Different HRD Tumor Status |
clinical trial |
Statements
Non-Randomized, Open-Label Phase II Study to Assess Olaparib Tablets as a Treatment for Subjects With Different HRD Tumor Status and With Platinum-Sensitive, Relapsed, High-Grade Serous or High-Grade Endometrioid Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That Have Received at Least 1 Prior Line of Chemotherapy (English)
0 references
22 December 2016
0 references
21 May 2020
0 references
272
0 references
18 year
0 references
130 year
0 references